Does tralokinumab have a higher rate of conjunctivitis versus dupilumab?Featuring Tina Bhutani, MD, MAS | Associate Professor, Department of DermatologyUniversity of CaliforniaSan Francisco, CA | Published February 16, 2023View video transcriptLoading...Related MediaPowered by Polaris TM